ROIV
Price
$10.65
Change
-$0.11 (-1.02%)
Updated
May 14, 02:38 PM (EDT)
Capitalization
7.68B
42 days until earnings call
UTHR
Price
$301.02
Change
-$7.05 (-2.29%)
Updated
May 14, 02:49 PM (EDT)
Capitalization
13.9B
77 days until earnings call
Ad is loading...

ROIV vs UTHR

Header iconROIV vs UTHR Comparison
Open Charts ROIV vs UTHRBanner chart's image
Roivant Sciences
Price$10.65
Change-$0.11 (-1.02%)
Volume$5.14K
Capitalization7.68B
United Therapeutics
Price$301.02
Change-$7.05 (-2.29%)
Volume$413
Capitalization13.9B
ROIV vs UTHR Comparison Chart
Loading...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ROIV vs. UTHR commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROIV is a Hold and UTHR is a Buy.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (ROIV: $10.76 vs. UTHR: $308.07)
Brand notoriety: ROIV and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROIV: 63% vs. UTHR: 160%
Market capitalization -- ROIV: $7.68B vs. UTHR: $13.9B
ROIV [@Biotechnology] is valued at $7.68B. UTHR’s [@Biotechnology] market capitalization is $13.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROIV’s FA Score shows that 0 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • ROIV’s FA Score: 0 green, 5 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than ROIV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROIV’s TA Score shows that 5 TA indicator(s) are bullish while UTHR’s TA Score has 7 bullish TA indicator(s).

  • ROIV’s TA Score: 5 bullish, 4 bearish.
  • UTHR’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than ROIV.

Price Growth

ROIV (@Biotechnology) experienced а -2.71% price change this week, while UTHR (@Biotechnology) price change was +4.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.76%. For the same industry, the average monthly price growth was +7.67%, and the average quarterly price growth was -5.25%.

Reported Earning Dates

ROIV is expected to report earnings on Aug 18, 2025.

UTHR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+1.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($13.9B) has a higher market cap than ROIV($7.68B). UTHR has higher P/E ratio than ROIV: UTHR (12.27) vs ROIV (1.97). ROIV YTD gains are higher at: -9.045 vs. UTHR (-12.688). ROIV has higher annual earnings (EBITDA): 4.1B vs. UTHR (1.65B). ROIV has more cash in the bank: 5.15B vs. UTHR (3.27B). ROIV has less debt than UTHR: ROIV (100M) vs UTHR (300M). UTHR has higher revenues than ROIV: UTHR (2.88B) vs ROIV (123M).
ROIVUTHRROIV / UTHR
Capitalization7.68B13.9B55%
EBITDA4.1B1.65B248%
Gain YTD-9.045-12.68871%
P/E Ratio1.9712.2716%
Revenue123M2.88B4%
Total Cash5.15B3.27B158%
Total Debt100M300M33%
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
54
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ROIVUTHR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 15 days ago
71%
Bullish Trend 7 days ago
69%
Declines
ODDS (%)
Bearish Trend 6 days ago
74%
Bearish Trend 24 days ago
58%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Ad is loading...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-2.09%
IMVT - ROIV
61%
Loosely correlated
-3.64%
ACLX - ROIV
54%
Loosely correlated
-2.10%
CRNX - ROIV
51%
Loosely correlated
-7.11%
KYMR - ROIV
51%
Loosely correlated
-3.20%
KRYS - ROIV
50%
Loosely correlated
-3.51%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-0.88%
DAWN - UTHR
43%
Loosely correlated
-3.80%
GERN - UTHR
37%
Loosely correlated
-6.25%
KRYS - UTHR
34%
Loosely correlated
-3.51%
VKTX - UTHR
34%
Loosely correlated
-2.00%
ROIV - UTHR
33%
Poorly correlated
-2.09%
More